Brief: SinoMab Bioscience Says HY Loss RMB143.8 Mln
22/08/2022 14:40
Aug 22 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* HY LOSS RMB143.8 MILLION VERSUS LOSS RMB114.4 MILLION
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience